Lessons from the withdrawal of rofecoxib: Observational studies should not be forgotten
AUTOR(ES)
Oakley, Godfrey
FONTE
BMJ Publishing Group Ltd.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=534853Documentos Relacionados
- Lessons from the withdrawal of rofecoxib: Patients would be safer if drug companies disclosed adverse events before licensing
- Lessons from the withdrawal of rofecoxib: France has policy for overall assessment of public health impact of new drugs
- Smoke free hospitals: Withdrawal from cigarettes should not be confused with withdrawal from nicotine
- Why a 1940s medical committee should not be forgotten
- Lawsuits mount in wake of rofecoxib (Vioxx) withdrawal